The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.24 | Sales 2021 | 12.35 16.82 | Capitalization | 22.37M 30.48M |
---|---|---|---|---|---|
Net income 2020 | -126M -172M | Net income 2021 | -85M -116M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 39.78M | Net Debt 2021 | 17.1M 23.3M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 6.09B | |
-21.28% | 4.14B | |
+4.52% | 3.23B | |
-18.16% | 2.83B | |
-7.70% | 2.39B | |
+41.50% | 1.9B | |
-4.05% | 1.57B | |
-15.56% | 1.55B | |
-14.62% | 1.5B |